Manulife (Manufacturers Life Insurance)’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.23M | Sell |
122,372
-2,854
| -2% | -$52K | ﹤0.01% | 1453 |
|
2025
Q1 | $2.48M | Buy |
125,226
+4,614
| +4% | +$91.5K | ﹤0.01% | 1407 |
|
2024
Q4 | $2.07M | Sell |
120,612
-6,105
| -5% | -$105K | ﹤0.01% | 1544 |
|
2024
Q3 | $2.53M | Sell |
126,717
-3,022
| -2% | -$60.4K | ﹤0.01% | 1473 |
|
2024
Q2 | $1.45M | Buy |
129,739
+18,977
| +17% | +$212K | ﹤0.01% | 1636 |
|
2024
Q1 | $731K | Buy |
110,762
+31,798
| +40% | +$210K | ﹤0.01% | 2032 |
|
2023
Q4 | $357K | Sell |
78,964
-1,784
| -2% | -$8.06K | ﹤0.01% | 2321 |
|
2023
Q3 | $289K | Hold |
80,748
| – | – | ﹤0.01% | 2392 |
|
2023
Q2 | $298K | Buy |
80,748
+11,933
| +17% | +$44K | ﹤0.01% | 2371 |
|
2023
Q1 | $228K | Hold |
68,815
| – | – | ﹤0.01% | 2475 |
|
2022
Q4 | $267K | Sell |
68,815
-3,015
| -4% | -$11.7K | ﹤0.01% | 2380 |
|
2022
Q3 | $175K | Sell |
71,830
-2,126
| -3% | -$5.17K | ﹤0.01% | 2643 |
|
2022
Q2 | $146K | Buy |
+73,956
| New | +$146K | ﹤0.01% | 2801 |
|
2021
Q1 | – | Sell |
-33,218
| Closed | -$865K | – | 3074 |
|
2020
Q4 | $865K | Sell |
33,218
-4,122
| -11% | -$107K | ﹤0.01% | 1901 |
|
2020
Q3 | $89K | Hold |
37,340
| – | – | ﹤0.01% | 2814 |
|
2020
Q2 | $110K | Sell |
37,340
-2,740
| -7% | -$8.07K | ﹤0.01% | 2724 |
|
2020
Q1 | $115K | Buy |
40,080
+8,908
| +29% | +$25.6K | ﹤0.01% | 2531 |
|
2019
Q4 | $125K | Buy |
31,172
+601
| +2% | +$2.41K | ﹤0.01% | 2739 |
|
2019
Q3 | $142K | Buy |
+30,571
| New | +$142K | ﹤0.01% | 2730 |
|